Weld Capital Management’s Amedisys AMED Stock Holding History

Weld Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,344	Closed	-$905K	–	718
2019 Q1	$905K	Buy	+7,344	New	+$922K	0.16%	233

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Weld Capital Management's AMED Position: Q2 2019 in Review

Weld Capital Management sold out of Amedisys (AMED) in Q2 2019, closing a stake of 7,344 shares — an estimated $905K sold.

Weld Capital Management first reported a position in AMED in Q1 2019 and held it in 1 quarter. The position peaked at $905K in Q1 2019. 285 funds tracked by Wall St. Rank hold AMED as of Q2 2019.

Weld Capital Management reported no remaining Amedisys position as of Q2 2019 after selling out during the quarter.
Weld Capital Management sold 7,344 Amedisys shares in Q2 2019, an estimated $905K.
Weld Capital Management first reported a position in Amedisys in Q1 2019 and held it in 1 quarter.
Weld Capital Management's Amedisys position peaked at $905K in Q1 2019.
285 funds tracked by Wall St. Rank held Amedisys as of Q2 2019.

Based on Weld Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.